#ClinicalEquality Sessions 5: Part 1

#ClinicalEquality Sessions 5: Part 1

Why do Black women face disproportionately higher mortality rates in breast cancer than white women? In this latest episode of #ClinicalEquality Sessions, Sommer Bazuro meets Dr Lisa Newman, a surgical oncologist who has dedicated her career to uncovering the reason behind these stark racial disparities in breast cancer. In Part 1 of their discussion, she explains what sparked her research interest in breast cancer outcomes among Black women. Her message: better outcomes for all women with breast cancer will require better racial representation in clinical trials. Learn more about Dr Newman’s research at bcrf.org/blog/lisa-newman-bcrf-research-icsbcs/ Learn more about The Trial for #ClinicalEquality at clinicalequality.com 00:00 – Introducing Dr Newman 00:58 – Dr Newman’s Focus on Breast Cancer Disparities 02:08 – Why Black Women May Be Underrepresented in Clinical Trials 04:55 – Triple-Negative Breast Cancer in Black Women 06:24 – An Urgent Need for Better Representation